Illumina inked a deal with Standard BioTools to acquire SomaLogic for $350 million in cash. The maker of gene-sequencing equipment and services said Monday that the deal includes an additional ...

Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

Stay up-to-date on Illumina, Inc. Common Stock (ILMN) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.

Find the latest historical data for Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.